Episode 559: SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes

POEM of the Week Podcast - En podcast af Mark Ebell and Michael Wilkes

Prøv Mofibo gratis i 30 dage!

Prøv Mofibo gratis i 30 dage!

Et univers med over 600.000 e- og lydbøger, klik her for at prøve

 Annoncering

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT-2 inhibitors or GLP-1 receptor agonists reduce cardiovascular outcomes in patients with type 2 diabetes '

Visit the podcast's native language site